<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-12T08:12:17+00:00">
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-NGA-C-IHVN-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for Impact Against HIV and Tuberculosis - Nigeria (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Nigeria, TB/HIV, Institute of Human Virology Nigeria</narrative>
    </description>
    <description type="2">
      <narrative>Goals: To accelerate efforts at ending TB epidemic in Nigeria by ensuring access to comprehensive and high quality patients' centered and community owned TB (TB. TB/HIV and DR-TB) services for all Nigerians by 2026; To end HIV epidemics by the year 2030. Objectives: To increase case notification rate of all forms of TB from 131/100,000 population in 2022 to 142/100,000 population in 2026; To sustain TB treatment success rate beyond the NSP 2021-2026 target of 90% during the grant period; To enrol 100% of diagnosed DR-TB patients on appropriate treatment by 2026; To understand HIV epidemiology (status, progress and forecast); To achieve 95-95-95 target by 2025.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Institute of Human Virology Nigeria</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Institute of Human Virology Nigeria</narrative>
    </participating-org>
    <other-identifier ref="NGA-C-IHVNP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Jean-Thomas Nouboussi</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>jean.nouboussi@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="NG" percentage="100">
      <narrative>Nigeria</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="67.67">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="18.01">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="14.32">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="f8950f0e-59db-4839-9e56-5ad9689ca68d" percentage="0.61">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for AGYW and their male sexual partners programs</narrative>
        </description>
      </budget-item>
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="2.32">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="891c6028-9f9a-427f-8e25-55b502d52054" percentage="2.17">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing outside of KP and AGYW programs</narrative>
        </description>
      </budget-item>
      <budget-item code="d0aef99a-6d26-4e24-9937-7363cf44e158" percentage="0.26">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e41c9e1f-dfcd-4d62-9a3d-2c6d760bb3af" percentage="0.26">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="26ab57aa-470b-4e99-bff9-92e1452cf6cd" percentage="0.69">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="ae365c24-71a9-48d4-b3ee-c436f513a41a" percentage="0.24">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for AGYW and their male sexual partners programs</narrative>
        </description>
      </budget-item>
      <budget-item code="48867067-7709-4cef-94a9-7dcc66211686" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="c7596dbc-702f-4654-8ff9-9bea34d5790c" percentage="0.36">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing outside of KP and AGYW programs</narrative>
        </description>
      </budget-item>
      <budget-item code="fa74be82-0e67-471f-99cd-c36d38ba6843" percentage="0.85">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Early infant diagnosis and follow-up HIV testing for exposed infants</narrative>
        </description>
      </budget-item>
      <budget-item code="54f285ef-8db0-40b2-8052-f00a00522b8d" percentage="8.74">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
        </description>
      </budget-item>
      <budget-item code="698ea3f4-346f-4df8-ab2e-c01a47bbccd9" percentage="0.24">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Prevention of incident HIV among pregnant and breastfeeding women</narrative>
        </description>
      </budget-item>
      <budget-item code="1ef60004-7321-4f53-93cf-6bdfa56924ef" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Retention support for pregnant and breastfeeding women (facility and community)</narrative>
        </description>
      </budget-item>
      <budget-item code="8549b926-d8fb-4fa0-b3b8-79fc250303b6" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Comprehensive sexuality education for adolescent girls and young women (AGYW) and adolescent boys and young men (ABYM)</narrative>
        </description>
      </budget-item>
      <budget-item code="9d329dd4-6e6b-430c-80f6-afb56fbbbacd" percentage="0.18">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Condom and lubricant programming for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="f9b562f4-a21f-4bc7-b20c-8ff6fa8aa1a6" percentage="0.18">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Condom and lubricant programming for male sexual partners of AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="0a745960-07a1-46b7-add6-90d0e9ec5fd4" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; HIV prevention communication, information and demand creation for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="1240f978-9714-4e2a-9e31-d18773f6e595" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Pre-exposure prophylaxis (PrEP) programming for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="5c4d112f-f0f4-4a20-8ac8-5c566f7aa322" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Removing human rights-related barriers to prevention for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="e71b58f8-6d5d-4f73-93c5-cea93aefb0c3" percentage="0.16">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for AGYW and male sexual partners in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="92423e34-c66c-47f4-9cac-58b9e0ea01fc" percentage="0.18">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Community empowerment for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="0.13">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="1.9">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="e14e7a7d-49ce-4bb6-8454-ae4224e7a32e" percentage="0.15">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="cfd9f41e-52ee-4b8f-a55c-e416fa546878" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Community empowerment for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="52020c8d-d3b6-42f6-9137-038784523b8a" percentage="0.35">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Condom and lubricant programming for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="97e87d65-a4de-4357-81ae-2aae27b112a2" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; HIV prevention communication, information and demand creation for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="8de4adae-a667-40e7-aadf-a32b8a82065a" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; Condom and lubricant programming for prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="7f6dabab-f06a-4957-b710-a1c3f2f37f3a" percentage="0.14">
        <description>
          <narrative>HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="1d7ecc3b-d5b9-48ca-a9e7-d8fa38cf3455" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Condom and lubricant programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="d4788f0c-523b-415c-b8ec-03eaa8789e31" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; HIV prevention communication, information and demand creation for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="f1547d57-4fe3-48f6-acd2-f3c9e4e016d1" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Needle and syringe programs for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="49ef45b6-ef30-48b1-b393-f34c25d513c4" percentage="0.46">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="aa067064-0a03-4f96-942d-39b437c0a76e" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Overdose prevention and management for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="e2889950-b814-4736-95c3-6957c4461ebe" percentage="1.22">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="d016d725-1006-44b1-8b50-da67f4621072" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="94dbd87e-0cec-46fb-83f5-7c805de185cb" percentage="0.64">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="4ad468bf-4376-466e-944a-b25f3e1b00ee" percentage="1.63">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="3f39233d-f679-42ce-8532-a7949f0d93ef" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="daac344e-ec8e-4193-9c8a-266fdd2e69ac" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="6853dd18-909c-4836-8981-2e434afc456c" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="ec84ef8b-ad12-46a3-9175-4f68245fa984" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="a4e4d0e7-9dfd-49d8-8030-0f9cc9b713fc" percentage="0.14">
        <description>
          <narrative>HIV -&gt; Prevention program stewardship -&gt; Prevention program stewardship</narrative>
        </description>
      </budget-item>
      <budget-item code="e6662a80-0f0d-4611-990c-6044696834dc" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy for human rights</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="0">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="ecc245de-32bf-41ff-8eb1-f5fae2eb1557" percentage="0.05">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights") (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="e0bd4666-bd16-440a-81d4-ded76d1d1b10" percentage="0.25">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
        </description>
      </budget-item>
      <budget-item code="530c3ad4-ec67-412e-9dc9-b83b6de6bf61" percentage="0.06">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced HIV disease (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="32.24">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="0.47">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="423a40f4-4716-48a1-9c6c-7b78ede223af" percentage="0.64">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Integrated management of common co-infections and co-morbidities (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="8.15">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="0.31">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="9.39">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="ee47d3a5-497f-4999-baac-60877b4cf497" percentage="0.12">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Integrated supportive supervision for health workers (excluding CHWs)</narrative>
        </description>
      </budget-item>
      <budget-item code="5a6fc5ba-08a3-455c-887d-00867a865303" percentage="0.07">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Quality improvement and capacity building for quality of care</narrative>
        </description>
      </budget-item>
      <budget-item code="f9c0078b-d557-4047-b352-b4b2eba7e5b8" percentage="0.34">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory Information systems</narrative>
        </description>
      </budget-item>
      <budget-item code="376b4c32-f875-4663-ba6e-759f6042be74" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory supply chain systems</narrative>
        </description>
      </budget-item>
      <budget-item code="09d00f5e-f29a-445c-a7e5-4a1e21a3dce7" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory-based surveillance</narrative>
        </description>
      </budget-item>
      <budget-item code="19ae85a9-12db-4fb8-9313-84f9feef29a0" percentage="0">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="0aa54232-09ea-488b-86df-48a82af99ed4" percentage="0.1">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="a964bfef-7776-4f8c-bf11-c2f904336a18" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Specimen referral and transport system</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="0.05">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="0.25">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="8c042996-0cb7-4540-ad17-483cf18ec784" percentage="0.11">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="48d7f7e3-61fc-4c8d-88f3-aefc44da79dc" percentage="0.61">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Planning and procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="78165abf-6e6d-46ad-b445-d380c1037123" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="38ed2119-0193-4f73-9333-90fbd5a8cc0b" percentage="0.16">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain information systems</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="0.47">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="1.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="cb85db5b-1f59-4c7a-ba74-2cb30ee6a84b" percentage="0.15">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Operational Research</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="0.58">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="85fbea77-53b5-4647-bd23-d3053191c7bb" percentage="0.4">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveillance for HIV, tuberculosis and malaria</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="0.12">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="0.1">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="1.79">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="7.24">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="0.08">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="1.13">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="8d2f8312-6339-4e40-9c64-84e09bb628b3" percentage="0.21">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Urban poor/slum dwellers</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="1.61">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="0.07">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="2.84">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="d98eb915-d64b-45bb-8bae-93a530d37d6e" percentage="0.77">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Community care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="2.19">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">31402685.23</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">99332019.60</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">175438684.52</value>
    </budget>
    <capital-spend percentage="2.4" />
    <transaction ref="ac510349-8a6a-4265-a69c-347182fe0888">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-20" />
      <value currency="USD" value-date="2023-12-20">67981885.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a7d7aafa-c80f-4c7b-9299-b725975a6e1d">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-22" />
      <value currency="USD" value-date="2023-12-22">14054847.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5ed7a921-c924-44c5-9dc2-db8271be9d50">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-03" />
      <value currency="USD" value-date="2024-05-03">20797.47</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="626ccc4d-14e6-4280-8bb5-150b8bf083f9">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-11" />
      <value currency="USD" value-date="2024-06-11">33499173.32</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d9bc7cc5-20e9-4882-a09e-a61ab31ccc93">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-19" />
      <value currency="USD" value-date="2024-06-19">377548.53</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="53ef5536-31a4-405b-8905-58f10ba85d59">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-19" />
      <value currency="USD" value-date="2024-06-19">-20797.47</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7da94ddf-6158-4864-9166-5a9925d29df5">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-20" />
      <value currency="USD" value-date="2024-06-20">564103.24</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3e566ba1-93fb-4b27-80df-405a4268e5bb">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-20" />
      <value currency="USD" value-date="2024-06-20">-377548.53</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d73f40d4-3007-4a14-a328-5a0e181cde59">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">33670124.34</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3eb89ab9-3376-4504-931b-86f3df500fe1">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">-33499173.32</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="890c758d-9030-4651-9d3f-2693b91fe736">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-26" />
      <value currency="USD" value-date="2024-06-26">-564103.24</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5286a61a-c27d-4253-8072-aa18a37c59ca">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-26" />
      <value currency="USD" value-date="2024-06-26">2997235.66</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d7bad704-4419-4e8f-bede-2a0f2e3d0bf8">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-09" />
      <value currency="USD" value-date="2024-07-09">-33670124.34</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1e958672-46bb-47bc-9aa8-2f0f1a67f4b4">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-09" />
      <value currency="USD" value-date="2024-07-09">33598174.64</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea0f4b67-2e2c-4454-ab48-4ea0909453ba">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-11" />
      <value currency="USD" value-date="2024-07-11">-2997235.66</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3972aa6c-dd9d-4680-8b3f-1df251eea404">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-11" />
      <value currency="USD" value-date="2024-07-11">3433844.91</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e5be475a-6afc-43ce-b0e5-2654d9b9075f">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-16" />
      <value currency="USD" value-date="2024-07-16">38428.37</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5525a7c0-c26c-491a-9b34-017eb05e5225">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-16" />
      <value currency="USD" value-date="2024-07-16">5637690.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9df96b66-80d8-4e9f-af76-d308a9e0714d">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-30" />
      <value currency="USD" value-date="2024-07-30">27311178.12</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3bcb8f2c-1eaf-4963-a77a-2017b544eb6d">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-30" />
      <value currency="USD" value-date="2024-07-30">-27922056.27</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="78797dac-ddc6-47a7-83fe-c68b76627b49">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-06" />
      <value currency="USD" value-date="2024-08-06">16538755.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="569d52d0-962a-4e3e-a91f-d81627a9c82e">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-06" />
      <value currency="USD" value-date="2024-08-06">1107126.29</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fd1887d6-1a35-472f-b082-2d90bf41c228">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-07" />
      <value currency="USD" value-date="2024-08-07">-3433844.91</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="72f2b938-d006-49fe-97c2-9a5ef7ef48bc">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-07" />
      <value currency="USD" value-date="2024-08-07">5385482.02</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d896102f-a4ad-4a16-8cbb-59568b730940">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-10" />
      <value currency="USD" value-date="2024-08-10">-27308309.44</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2bfab457-2d56-4188-bc69-5856c80656b4">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-10" />
      <value currency="USD" value-date="2024-08-10">27308404.99</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1ef21201-fdee-4f79-92f1-ecdad0d6fa63">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-10" />
      <value currency="USD" value-date="2024-08-10">-95.55</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4900b25e-e7e8-4913-8ad8-279e6ecd33d6">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-13" />
      <value currency="USD" value-date="2024-08-13">2868.68</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="121b60c4-f619-48e2-a6f6-e6addb6a4e2e">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-08-13" />
      <value currency="USD" value-date="2024-08-13">95.55</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2b375532-079c-4ca6-95ca-3453ad88ed52">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-13" />
      <value currency="USD" value-date="2024-08-13">5427243.06</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0dc5ae07-73eb-403b-82d7-afe19ae9d664">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-13" />
      <value currency="USD" value-date="2024-08-13">-5385482.02</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d6570437-c9e3-4b9d-885d-b6b24a886b95">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-22" />
      <value currency="USD" value-date="2024-08-22">27508733.06</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aad32041-082c-4dfa-a404-98bd02051498">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-22" />
      <value currency="USD" value-date="2024-08-22">-27308404.99</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="40a36046-0714-4e3f-b222-e87fa28f5e77">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-29" />
      <value currency="USD" value-date="2024-08-29">1019810.36</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d4763e9d-c4ae-405d-bb94-f30fa3ad7631">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-04" />
      <value currency="USD" value-date="2024-09-04">1130729.09</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4b765033-3cb1-49c6-9058-9130344196fd">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-04" />
      <value currency="USD" value-date="2024-09-04">-1107126.29</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="40f845af-5e6a-445b-9e7a-c57a500a8583">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-19" />
      <value currency="USD" value-date="2024-09-19">33704.24</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f2b2d7a0-b87e-4ea3-86c9-daa2af6dd41f">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-20" />
      <value currency="USD" value-date="2024-09-20">27475063.82</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e9290572-cd49-4bb2-9954-1c1c7504eaf0">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-20" />
      <value currency="USD" value-date="2024-09-20">-35.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c0609847-1552-48b2-bf90-e767c6ff4d4e">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-20" />
      <value currency="USD" value-date="2024-09-20">-27475028.82</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="87758bc0-5161-4ee4-a0e1-3075fc46a423">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-09-24" />
      <value currency="USD" value-date="2024-09-24">35.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8b6c9d07-f84a-4611-91e3-4b2cae91e78f">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-24" />
      <value currency="USD" value-date="2024-09-24">3660419.86</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5a3aae10-3ea0-4f05-98bd-8c4e1c259d2f">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-26" />
      <value currency="USD" value-date="2024-09-26">11341.03</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="63664f08-7fd2-4a02-aaf3-d9150f043620">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-08" />
      <value currency="USD" value-date="2024-10-08">309706.12</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fdfc30fb-43c1-4530-96c5-eb2dcbb4f586">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-10" />
      <value currency="USD" value-date="2024-10-10">4412474.29</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9f3b1487-9c99-412e-b4e9-e61e0b01d128">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-10" />
      <value currency="USD" value-date="2024-10-10">1774600.98</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="50edb11b-3ca6-413b-9ae0-fdf7ada00184">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-10" />
      <value currency="USD" value-date="2024-10-10">286739.28</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="de025017-f7e3-4f87-8626-d8d518c5e7d4">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">23364.90</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="bce299bc-e05a-4627-b61e-3b263b15551d">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">202652.10</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c0457da3-943c-4532-b36a-24a39d9a3342">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">38428.37</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="38ca622a-3355-425b-afb2-0f0b0bfd9671">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">57369.83</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="21c84502-0ea6-4ce4-a35e-b7a64789beef">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">821954.48</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b4a9c0c4-d953-4aab-800f-9ba650922df6">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">16618025.58</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9bfd963b-122f-4de0-9cb6-6fbb01a96969">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">-16579597.21</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="57d1eac4-f42f-429b-bd63-34ae266ee751">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">-38428.37</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="16700318-ce2d-4c5d-ba56-4467aad13b52">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-17" />
      <value currency="USD" value-date="2024-10-17">348786.27</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3473717e-cedb-4c9b-96c0-23d63af231e0">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-22" />
      <value currency="USD" value-date="2024-10-22">103738.94</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ef8caa47-92f5-4a4b-879a-73fcc418345d">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-25" />
      <value currency="USD" value-date="2024-10-25">-16269239.31</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="95c4184c-ed71-40e8-9b13-5bfdd9d006a4">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-25" />
      <value currency="USD" value-date="2024-10-25">16259075.35</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f09a34b0-58f9-4006-8129-202254bb921e">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-29" />
      <value currency="USD" value-date="2024-10-29">19027.63</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="40f7ffae-8b91-4d17-bca8-8310e7a2f467">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-29" />
      <value currency="USD" value-date="2024-10-29">7449.49</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="03008fa3-c52e-47f5-bd81-badf110091dd">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-30" />
      <value currency="USD" value-date="2024-10-30">-16240047.72</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="761346ac-6e54-436b-a822-2471effc19e3">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-30" />
      <value currency="USD" value-date="2024-10-30">-610.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4a16a55d-92fd-413d-a3cc-07570b3e08bb">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-30" />
      <value currency="USD" value-date="2024-10-30">16240657.72</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b61e958c-112d-4c24-b3cb-ddd7c9e7a370">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-01" />
      <value currency="USD" value-date="2024-11-01">28265.50</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9afe12fd-c9aa-40ef-a54b-af76017e6a0a">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-11-01" />
      <value currency="USD" value-date="2024-11-01">610.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bd2f4ec5-f832-4dea-981c-4a40eb198af7">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-02" />
      <value currency="USD" value-date="2024-11-02">16212402.22</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="87fbc1a8-3bd7-4c05-9c31-6b71b0d20fd6">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-02" />
      <value currency="USD" value-date="2024-11-02">-10.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="80848181-53d5-43d4-a990-288b5663771a">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-02" />
      <value currency="USD" value-date="2024-11-02">-16212392.22</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="eadc8129-8b83-488b-ba8f-a69db845c721">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-11-06" />
      <value currency="USD" value-date="2024-11-06">10.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="156fe561-4bde-455a-9143-cf607484e85a">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-07" />
      <value currency="USD" value-date="2024-11-07">6729238.36</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="387eb9cf-428f-4ac3-9b4f-536ef877d330">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-12" />
      <value currency="USD" value-date="2024-11-12">440981.88</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0733f3b0-3d03-4e17-ad29-f85e30a305dd">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-12" />
      <value currency="USD" value-date="2024-11-12">7749.12</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1bc625ee-4ffe-4390-bd50-9a314c8895b6">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-14" />
      <value currency="USD" value-date="2024-11-14">3612944.52</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="908d67b7-c406-4c53-bcb8-4599a76d1c64">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-21" />
      <value currency="USD" value-date="2024-11-21">17820.95</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="eefa3e9e-e514-4672-a89b-565c22290616">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-05" />
      <value currency="USD" value-date="2024-12-05">1711600.71</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="315be3ea-c67f-466c-a498-f0accbdd8ea5">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-05" />
      <value currency="USD" value-date="2024-12-05">-1130729.09</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4e003b1e-baf2-4bcc-99b2-17b5e2e84aa5">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-06" />
      <value currency="USD" value-date="2024-12-06">210510.27</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fdb3e6d5-4e8e-43c9-9834-15052759c88e">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-06" />
      <value currency="USD" value-date="2024-12-06">-5659709.07</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="601433f1-e817-4af8-8156-ef6383de1675">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-06" />
      <value currency="USD" value-date="2024-12-06">6250459.46</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fcd2c712-bcd3-496c-a73a-c9d9d1d0f5bf">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-12" />
      <value currency="USD" value-date="2024-12-12">166753.73</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4fe48d97-dd65-4e7c-bc54-40eaf2fb3ab7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-12" />
      <value currency="USD" value-date="2024-12-12">39534.75</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="cea206fb-086c-4713-b1bc-2453c85d92c3">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-17" />
      <value currency="USD" value-date="2024-12-17">5597.23</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6c87995e-69f2-4bba-8b5d-c88bc51b87e7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-17" />
      <value currency="USD" value-date="2024-12-17">752.90</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c4561ace-59c0-4626-bdf0-cb15dd48428c">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-18" />
      <value currency="USD" value-date="2024-12-18">19544.31</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c248b004-4657-4d5f-9483-850153cf35e8">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-18" />
      <value currency="USD" value-date="2024-12-18">286760.62</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e7a88fd7-5253-46a3-b2d8-19de83d84b64">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-07" />
      <value currency="USD" value-date="2025-01-07">2658.32</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6e151482-151d-456e-bc1e-7aadabba0b39">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-07" />
      <value currency="USD" value-date="2025-01-07">120618.42</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2789a364-91ed-4843-bb02-f151233d0464">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-07" />
      <value currency="USD" value-date="2025-01-07">214952.52</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a6fe79a7-aa77-4a12-87fe-3778ee2fa0ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-09" />
      <value currency="USD" value-date="2025-01-09">27448.15</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b5803b3b-a1a6-4abf-9ce9-b2f8bee3f91a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-01-11" />
      <value currency="USD" value-date="2025-01-11">-5711678.19</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5d3df470-0fe4-4185-98cd-a0faf0a48be2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-01-11" />
      <value currency="USD" value-date="2025-01-11">6118245.22</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7a2dc99d-90c0-4500-b38c-fd175ab54138">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-14" />
      <value currency="USD" value-date="2025-01-14">883252.13</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4beb8724-e8c6-4de4-bfce-90e0f93bbd8d">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-14" />
      <value currency="USD" value-date="2025-01-14">158238.36</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="23fe2b56-efe1-452f-b88e-8c8bb36b9632">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-14" />
      <value currency="USD" value-date="2025-01-14">116894.49</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d53fa052-2c4b-4888-9c56-b90d5e70826a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-16" />
      <value currency="USD" value-date="2025-01-16">604474.42</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8dcba491-e8e6-44be-89ed-82f13db044f3">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-21" />
      <value currency="USD" value-date="2025-01-21">81591.96</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="84343a54-8519-4dff-88ef-8da3a500b21d">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-21" />
      <value currency="USD" value-date="2025-01-21">8717.76</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="18a21c59-9178-4c19-a6bf-a2755bb93465">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-21" />
      <value currency="USD" value-date="2025-01-21">2162.67</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c16fae07-844a-40ff-b63b-b7ea6dddc3dc">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-28" />
      <value currency="USD" value-date="2025-01-28">1539140.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fbabe83e-9b32-4cbe-81a9-8bc5f68e5db0">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-11" />
      <value currency="USD" value-date="2025-02-11">53991.16</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0a81c6de-4714-4a45-833b-a0b5bc63e58e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-11" />
      <value currency="USD" value-date="2025-02-11">18403.71</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c88504a0-efe0-42fa-b966-131ccda434cf">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-13" />
      <value currency="USD" value-date="2025-02-13">1852.50</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="41c73016-e31a-4761-b653-0d36bfa79506">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-18" />
      <value currency="USD" value-date="2025-02-18">152944.26</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fe478d26-f3b3-456d-bd2b-ae4868470864">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-18" />
      <value currency="USD" value-date="2025-02-18">1784472.05</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a3e9466c-b32e-4003-b7a7-c4a60f204d37">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-18" />
      <value currency="USD" value-date="2025-02-18">-1649741.14</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fe770a0e-55c3-4097-8a5a-d4d6bd7b1520">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-26" />
      <value currency="USD" value-date="2025-02-26">-5809151.46</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="147538e6-5075-43ef-b3eb-22b8583c4082">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-26" />
      <value currency="USD" value-date="2025-02-26">44587176.44</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="07f46a6d-e8ee-4585-afaf-eed1bfaf738c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-04" />
      <value currency="USD" value-date="2025-03-04">-1784472.05</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c866774d-cc6b-4e0b-a93c-f87ea2c1f672">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-04" />
      <value currency="USD" value-date="2025-03-04">15192671.98</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0b91c787-1b17-42bd-9b30-2f6ad469eb60">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-18" />
      <value currency="USD" value-date="2025-03-18">6842435.80</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="286f1798-cd4e-4804-ade3-0d8b24de6a0a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-18" />
      <value currency="USD" value-date="2025-03-18">9709600.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="90f178d3-f9d2-4bc3-9b01-081f0aa5ce5f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-21" />
      <value currency="USD" value-date="2025-03-21">17244583.82</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="271efca4-28d3-4f66-a1e0-eed2c915602a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-21" />
      <value currency="USD" value-date="2025-03-21">-15192671.98</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cc769b46-133b-445b-91e3-35deae2fbf8b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-23" />
      <value currency="USD" value-date="2025-03-23">17240788.76</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="459195fb-dff6-4246-b319-76c0a40328e2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-23" />
      <value currency="USD" value-date="2025-03-23">-17244583.82</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fc6ac846-d1ba-4d24-85b4-f78915519fcb">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-25" />
      <value currency="USD" value-date="2025-03-25">-17240788.76</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4721a3bc-a2ac-45e8-9a62-deed239c0db1">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-25" />
      <value currency="USD" value-date="2025-03-25">18029812.75</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f4c710f8-dae5-4c4c-995b-f55060a9975e">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-26" />
      <value currency="USD" value-date="2025-03-26">44585430.80</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="992a3b3e-25e2-4b60-811f-af48ee973cff">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-26" />
      <value currency="USD" value-date="2025-03-26">-44587176.44</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d5bad732-1d44-4c9c-bd21-1aa057d4e5a7">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">27703.10</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8dcda57d-20bb-456f-8c5f-dd37a623dc02">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">1107481.90</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f84d9ecd-18f2-465d-a76f-f7a5af30efe6">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-01" />
      <value currency="USD" value-date="2025-04-01">214412.39</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f2efbc84-9833-4533-ad02-16c3b6ac329a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-01" />
      <value currency="USD" value-date="2025-04-01">24598.66</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="75d1305b-88a5-44a5-93d9-e65c45b32bea">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-01" />
      <value currency="USD" value-date="2025-04-01">17736.28</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9836ee79-0d07-48fd-9d02-cb2547a4654d">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-04-01" />
      <value currency="USD" value-date="2025-04-01">17018275.10</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="32eacc10-e6aa-41a5-9c56-e140367b26a1">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-04-01" />
      <value currency="USD" value-date="2025-04-01">-16894627.75</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="caca1b5e-7910-4c6d-9f3d-2d4ea728a7b1">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-08" />
      <value currency="USD" value-date="2025-04-08">61041.70</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="65e42aa7-f556-4979-a005-86a49ca71b40">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-08" />
      <value currency="USD" value-date="2025-04-08">197199.63</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6af88c38-2863-4bee-9045-4a2f872ee6c0">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-08" />
      <value currency="USD" value-date="2025-04-08">136089.57</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="63b65e22-5380-4d84-8212-a47759a1693e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-08" />
      <value currency="USD" value-date="2025-04-08">1637431.81</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="27aa15a2-19a3-4d07-be81-3659cd5c680a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-08" />
      <value currency="USD" value-date="2025-04-08">9263.10</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="187483db-6845-4bc9-b362-1cefdb748981">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-08" />
      <value currency="USD" value-date="2025-04-08">451378.59</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="349ed7dc-86cf-41ed-9cfb-f373bedb0b4e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-15" />
      <value currency="USD" value-date="2025-04-15">84.72</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8522c257-5e76-46c7-8008-95c6ef6705b7">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-17" />
      <value currency="USD" value-date="2025-04-17">1291707.15</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="eaa3ea42-4c67-4669-9676-04a64d3b0fed">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-22" />
      <value currency="USD" value-date="2025-04-22">8814.60</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a3fcbbfd-d105-4a1b-ac68-5a06ce8724e0">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-22" />
      <value currency="USD" value-date="2025-04-22">40979.91</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a2ad7e40-c52e-4d6e-8249-1b34522bcfc6">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-22" />
      <value currency="USD" value-date="2025-04-22">8999.48</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="baadc900-893f-4e9a-b28d-f72a08d5060f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-24" />
      <value currency="USD" value-date="2025-04-24">2391943.25</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="53e0c7bb-09a0-4ba6-8005-ded2e004909c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-24" />
      <value currency="USD" value-date="2025-04-24">19114.81</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9ea65ba5-d0b8-4504-b6d4-6de81cc6f301">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-28" />
      <value currency="USD" value-date="2025-04-28">11253.13</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="dc57346d-fbe5-4cc6-8166-385db0a99c3d">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-02" />
      <value currency="USD" value-date="2025-05-02">-41756295.52</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a2cfa55b-74f2-41e9-bb40-d7b55b3e438e">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-02" />
      <value currency="USD" value-date="2025-05-02">40845338.61</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4b5a5c66-4486-4d18-b513-cc6fb594a53d">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-08" />
      <value currency="USD" value-date="2025-05-08">1038503.99</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f8df2d11-a398-454c-be91-ec8db6638a5a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-19" />
      <value currency="USD" value-date="2025-05-19">15194026.35</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9a3a5371-d774-4ae2-8296-cd07113809d4">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-19" />
      <value currency="USD" value-date="2025-05-19">-12286857.61</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e3fe53e5-6287-4891-86cd-5877db9b4ae5">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-23" />
      <value currency="USD" value-date="2025-05-23">-40845338.61</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3bf6d900-e919-4e50-96c2-82b28c8fd486">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-23" />
      <value currency="USD" value-date="2025-05-23">38501187.22</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7fb1215f-775d-4d45-8583-b62136460137">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-25" />
      <value currency="USD" value-date="2025-05-25">-38501187.22</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2af805a5-bbb4-44b7-9584-b2904a151459">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-25" />
      <value currency="USD" value-date="2025-05-25">38452085.46</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6de44790-75e1-4137-8cad-28a466eb306e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-27" />
      <value currency="USD" value-date="2025-05-27">1619775.68</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="003c5dda-6bb4-482c-9056-885674bffa67">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-27" />
      <value currency="USD" value-date="2025-05-27">690864.29</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b45c9ed1-f071-4d37-94f7-35c2d62ef8a4">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-28" />
      <value currency="USD" value-date="2025-05-28">-13574250.67</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="44cadc27-70b4-4efa-8db3-42d2f1d43295">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-28" />
      <value currency="USD" value-date="2025-05-28">13558736.48</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="94fc4230-9f35-45a8-9ba9-a43fb8b5b764">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-03" />
      <value currency="USD" value-date="2025-06-03">11754549.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ea19b99b-c954-44b3-af4c-a74ef17f4f9e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-03" />
      <value currency="USD" value-date="2025-06-03">2882.58</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="45e03cb1-93c1-4f12-9ace-05680dd9d80e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-03" />
      <value currency="USD" value-date="2025-06-03">7820.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="be7c69df-14c8-4a13-9c45-8fcfe9e15e0e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-11" />
      <value currency="USD" value-date="2025-06-11">2964.41</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0ab29ec1-9064-4a79-b49e-ae79b18b71c5">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-17" />
      <value currency="USD" value-date="2025-06-17">1976.44</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="05969872-6be5-4a91-91e8-12453fcc79df">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-24" />
      <value currency="USD" value-date="2025-06-24">4167.74</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7e56357c-bd2a-492b-ae26-3519bf940a9c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-24" />
      <value currency="USD" value-date="2025-06-24">1833099.45</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7048fc1a-c859-444d-a9a4-6040748b5344">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-24" />
      <value currency="USD" value-date="2025-06-24">1896578.60</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="64112596-6858-413f-976e-8eb2e43e108e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-24" />
      <value currency="USD" value-date="2025-06-24">165592.84</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6bb8d1d9-7f8a-4dd6-8bf7-39daff327408">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-24" />
      <value currency="USD" value-date="2025-06-24">1689209.24</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="25810e89-dbb7-48f2-a0ff-4357a941becc">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-24" />
      <value currency="USD" value-date="2025-06-24">615300.99</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="cc6fea21-a721-4c2f-92f6-563078ffd282">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-24" />
      <value currency="USD" value-date="2025-06-24">12427.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="97e7fc89-9799-4ad6-b573-8ff5b400eb10">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">1760547.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea12828d-5b34-42d6-924d-9dc098161020">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">1760547.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="35b538f6-c1a1-417d-a9be-729a37d41306">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">104755.90</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5cd64a83-2051-4518-9762-7169c7ff6afb">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-05" />
      <value currency="USD" value-date="2025-07-05">-35886937.95</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="34e40a10-eaad-48b8-9e4a-84583c0d8b0f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-05" />
      <value currency="USD" value-date="2025-07-05">32704257.53</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b687d2cb-8878-4e95-aaab-c06bedf5fcb3">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-08" />
      <value currency="USD" value-date="2025-07-08">11617.55</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2f19f9d6-f687-4fe7-b866-36cb2e0b7589">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-08" />
      <value currency="USD" value-date="2025-07-08">5510695.39</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0edc6cde-26b4-4933-ac3e-2afd920e7b07">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-08" />
      <value currency="USD" value-date="2025-07-08">1979643.23</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5a5ffa13-ac43-4540-ba82-c8fa071d0687">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-15" />
      <value currency="USD" value-date="2025-07-15">1340.86</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="db345f5d-ed9a-402c-813d-2c727418a254">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-18" />
      <value currency="USD" value-date="2025-07-18">-7808275.02</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a4ed7fff-9723-46bd-b149-053236c582c0">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-18" />
      <value currency="USD" value-date="2025-07-18">7827282.42</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4026a8f0-9ec6-460c-a1a8-75d52644f479">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-18" />
      <value currency="USD" value-date="2025-07-18">-19007.40</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="02a7ca30-2255-4d39-a4a8-55a8fc96da48">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">18294.62</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="991c7da6-7aa2-436e-91ec-76b79d65096e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">20449.35</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0ee9e40c-1623-47d5-94a2-32fa48f38b00">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">2413.73</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ada98df0-011a-4240-8c38-4d256a9edac5">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">-7827282.42</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a1319a24-6592-4773-a51b-a58bf94f900f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">7718738.67</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="67a5ceb9-153f-4fd2-9bf6-dd508066c897">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-25" />
      <value currency="USD" value-date="2025-07-25">7718704.59</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="50ea546d-e5ee-4b93-895d-effe57757ca1">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-25" />
      <value currency="USD" value-date="2025-07-25">-7718738.67</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="26622f9e-7c5b-498f-857a-4b74c23de8f0">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">19007.40</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1beafe2e-10d3-4213-9cba-386662b30751">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">122024.54</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fc443610-b6b2-4625-9f5e-2faf9211b8d2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">7472341.82</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1714ec59-d14d-4c93-928a-dee905990274">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">-7718704.59</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f9bc3e14-e92f-4a3f-ad28-f50d8f2d59bb">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-01" />
      <value currency="USD" value-date="2025-08-01">-27014340.19</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ef1a1eb0-4f87-467e-ba08-21985746133b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-01" />
      <value currency="USD" value-date="2025-08-01">26926629.18</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e3425bbe-7773-43f7-a623-b3af5ca8a0fc">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-05" />
      <value currency="USD" value-date="2025-08-05">1873786.16</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9ff395fc-dcdb-491a-9a1f-3157e13b2796">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-05" />
      <value currency="USD" value-date="2025-08-05">14698.85</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9a548e73-f269-4b4d-8ed1-d0c3dca2d695">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-05" />
      <value currency="USD" value-date="2025-08-05">446040.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9b7d18d7-a222-4cd1-b4dd-a16cbf800610">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-05" />
      <value currency="USD" value-date="2025-08-05">173702.80</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="083359f5-d4e8-4f92-9213-8bcac6a1d9d9">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-05" />
      <value currency="USD" value-date="2025-08-05">2362129.37</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="01fd397d-7dac-4c3d-8322-1c4540f46283">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-09" />
      <value currency="USD" value-date="2025-08-09">-4745984.11</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a41a9bfb-2810-4ce6-8cb1-75465cce0abc">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-09" />
      <value currency="USD" value-date="2025-08-09">4659612.78</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fcf0be57-60f5-4b28-9ef6-69deb8f99b57">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-12" />
      <value currency="USD" value-date="2025-08-12">232828.75</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b8b7c11e-7f43-496c-8604-9f8e0e9f620f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-12" />
      <value currency="USD" value-date="2025-08-12">601783.50</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b469e300-fa2d-419b-b064-b4b707301ea8">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-12" />
      <value currency="USD" value-date="2025-08-12">114.24</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6cc5229d-7592-4a78-9990-2eeb2abb8885">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-12" />
      <value currency="USD" value-date="2025-08-12">3165.73</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="057c7a14-c235-40e7-befc-32b9518c97e7">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-19" />
      <value currency="USD" value-date="2025-08-19">3884347.08</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="aeae8d81-228c-4e48-af8e-a16c251ea615">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-19" />
      <value currency="USD" value-date="2025-08-19">3682.55</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7bcffbcb-14a6-481a-bde1-b213ef862191">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-19" />
      <value currency="USD" value-date="2025-08-19">7878.48</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b08312dc-6600-4fb9-85f5-3df7743a7c77">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-22" />
      <value currency="USD" value-date="2025-08-22">4056456.28</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5b088771-f45a-4203-b474-2b954df547cb">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-22" />
      <value currency="USD" value-date="2025-08-22">-4057829.28</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b26f3b13-8e62-418a-ac1e-a08d8ad63b24">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-26" />
      <value currency="USD" value-date="2025-08-26">18283.62</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="57f999f1-f402-4e5d-9434-6cd46e09afd1">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-26" />
      <value currency="USD" value-date="2025-08-26">34539.13</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1c541982-f4fe-4725-b89f-6e1f3da7604a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-26" />
      <value currency="USD" value-date="2025-08-26">1082050.37</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="98416e4f-bb8a-4ef7-b59f-2f06946d77ad">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-03" />
      <value currency="USD" value-date="2025-09-03">65797.23</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="852840d7-9724-4981-8aca-ad0eafcb9fbe">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-03" />
      <value currency="USD" value-date="2025-09-03">63957.47</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5de2d312-afd2-465b-bd74-8e243bcec219">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-03" />
      <value currency="USD" value-date="2025-09-03">317961.37</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="24d0b933-0ac5-4626-b3c3-f66eba371869">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-03" />
      <value currency="USD" value-date="2025-09-03">29535.61</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="12c47b7b-5476-4915-8b1c-1538d4542856">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-03" />
      <value currency="USD" value-date="2025-09-03">8392.03</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8268a20e-4f19-4899-87ef-4e2f5169d06c">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-10" />
      <value currency="USD" value-date="2025-09-10">621.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="166bff62-46e9-4872-8db1-0f71ca1c26e3">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-16" />
      <value currency="USD" value-date="2025-09-16">50890.68</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7a9a8158-b543-4cd9-b305-074ae503aa9a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-22" />
      <value currency="USD" value-date="2025-09-22">-621.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e8e737d5-2b48-4906-b6ca-57668c4e6853">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-23" />
      <value currency="USD" value-date="2025-09-23">1045.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ec7e5234-b5ae-409f-80fd-841224b7cfa2">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">37778.62</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d38cb3e3-b987-4549-a3bc-8646cc6f1ad0">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">59241.46</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4b9f1ac9-6442-4244-9bc9-de31dbc63ce5">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">130440.91</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3e66e88f-1e19-4a8a-a33f-a27281f2d1ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">6612.86</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1af3614c-27c1-4fad-80e5-119fe9be28b9">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">1081521.71</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="bc766ec2-8415-44ac-a8a1-db3ac19b2a87">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-06" />
      <value currency="USD" value-date="2025-10-06">3877641.50</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="387b3ee9-6498-4a2c-9869-cf6b624af195">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-06" />
      <value currency="USD" value-date="2025-10-06">-25075.92</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0ef0c579-b693-475f-8669-64ee19e12092">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-06" />
      <value currency="USD" value-date="2025-10-06">-3906024.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a8b855dc-1400-4a26-8501-ea8873c06b29">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-08" />
      <value currency="USD" value-date="2025-10-08">-3877641.50</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9f1b970d-391a-49ca-becf-778ff7ef695a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-08" />
      <value currency="USD" value-date="2025-10-08">-906.95</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="66b64c40-a0fd-461c-8dd8-0f91b3e53873">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-08" />
      <value currency="USD" value-date="2025-10-08">3878548.45</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="013bed19-d95d-456d-afad-d4799fd80997">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-10-14" />
      <value currency="USD" value-date="2025-10-14">906.95</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d7f42e5b-7992-4614-966f-674d864d160b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-14" />
      <value currency="USD" value-date="2025-10-14">248219.27</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="cba140df-a69f-4a70-a70f-5cc1e84b66ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-14" />
      <value currency="USD" value-date="2025-10-14">3460.45</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="50781284-a267-49f6-a1cf-abcb99935f4c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-14" />
      <value currency="USD" value-date="2025-10-14">39154.57</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="482415e7-cd6b-470a-baa9-83379975b8ee">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-14" />
      <value currency="USD" value-date="2025-10-14">38549.61</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8ed2ad2e-1d8d-49f0-af92-35323c1417d3">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-14" />
      <value currency="USD" value-date="2025-10-14">-6839266.91</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2e1ce5a0-c44b-4307-b3a6-45c91817c7f2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-14" />
      <value currency="USD" value-date="2025-10-14">13642319.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="54437f3d-2d12-4461-af7a-87b4cf08320d">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">13627319.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e78dd3d4-6f8b-41e2-99fc-a74902bb8a96">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">2347.05</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9f33aac1-4455-4ca6-9438-6796e47e8d8a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">97726.13</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="99d012db-2a69-4a68-8e5d-8392c425382c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">4794.23</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5b4e5616-8257-4d4a-af0a-77cb62b4da8a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">6690.57</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="56249696-0fa0-427f-bc48-8ca0a1d7f8e5">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">20691.85</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="537be479-7b42-4df9-ab99-7bfa45dfd722">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">97870.23</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ab300de5-2092-424b-b0bb-f7d1ae1b9854">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-23" />
      <value currency="USD" value-date="2025-10-23">4700696.19</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9357a11f-08c0-430a-830c-7ada5551d287">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-23" />
      <value currency="USD" value-date="2025-10-23">-3741667.75</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a6b9dd3a-90a0-4568-926f-2c7146a8e39d">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-28" />
      <value currency="USD" value-date="2025-10-28">119150.24</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6e86a250-24b6-4d65-8c70-d9b5aaeca73e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-28" />
      <value currency="USD" value-date="2025-10-28">77405.88</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5cabff30-bb6e-4096-bbef-9ddb9e973b3c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-28" />
      <value currency="USD" value-date="2025-10-28">4403493.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="cbc81c73-3cff-4498-b10c-4369194051b2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-02" />
      <value currency="USD" value-date="2025-11-02">15570073.93</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7c3aed3d-fda2-444f-9143-3f647bd7a08e">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-02" />
      <value currency="USD" value-date="2025-11-02">-13887073.93</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cd875837-9952-48f8-9936-3951f0ac3e5b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">991172.24</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3dce27b9-a9da-4bb3-b27b-6ea49193aee1">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">105829.07</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="aa230a75-1315-4f84-a211-023c935cc8cd">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-05" />
      <value currency="USD" value-date="2025-11-05">15561073.93</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="248e2e3e-0455-4c23-9d4a-e7a5cc9f5f35">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-05" />
      <value currency="USD" value-date="2025-11-05">-15570073.93</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="badb1ce9-d8c0-44bc-97be-3d9bb6326357">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-14" />
      <value currency="USD" value-date="2025-11-14">5887011.88</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="739a287d-5987-44ca-b4a4-321080e03615">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-14" />
      <value currency="USD" value-date="2025-11-14">-3603694.88</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d9248c4b-3a20-4dff-8593-24f745afeb5f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-18" />
      <value currency="USD" value-date="2025-11-18">52608.78</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8f30ffb8-4ba3-49ed-9ea0-a4fe8415072b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-18" />
      <value currency="USD" value-date="2025-11-18">12426.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f833706c-7c26-424e-9692-4aaaf6bcd889">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-25" />
      <value currency="USD" value-date="2025-11-25">37168.19</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8b851ded-72e5-469b-a56e-dbd6252c9467">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-02" />
      <value currency="USD" value-date="2025-12-02">60969.70</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6bf3b7cc-9602-4bca-aaf6-893f404b91b8">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-02" />
      <value currency="USD" value-date="2025-12-02">14185.87</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="cd758d56-3c22-4ae4-b4e7-e6d4633df850">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-02" />
      <value currency="USD" value-date="2025-12-02">11381879.70</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="27274898-988b-4ca5-8eba-5c21ac1f6b82">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-02" />
      <value currency="USD" value-date="2025-12-02">-5722079.34</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="eccbdabb-3ab8-4ddb-acfc-9a385bca89fd">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">8670.93</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f1c2efa2-e621-4572-9a3b-ee2d939ac85c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">2701.76</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e9d1f0fc-d4b1-4ba7-b870-91df093b886c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">2067610.74</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d883a06f-4064-4214-9064-6583995d7531">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">38823.88</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ad4846ac-fdfb-4406-99b7-df29a707ab5b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">5780.62</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="462b6679-3362-4d36-a619-0754476ccd09">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">389131.04</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3ec3f20f-193f-491e-9da8-68f847fc19d9">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">8636.33</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b73de933-913d-4686-bf7c-3d669c6c3b4e">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-11" />
      <value currency="USD" value-date="2025-12-11">-13039718.63</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0ea46208-79b5-47e8-a705-88abc1a6a316">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-11" />
      <value currency="USD" value-date="2025-12-11">26257951.42</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b09625d1-d1ef-4b1b-8fc5-ab98c70b54e8">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-15" />
      <value currency="USD" value-date="2025-12-15">11061977.12</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6986d72f-b605-49b6-b096-e3699c37efeb">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-15" />
      <value currency="USD" value-date="2025-12-15">-11064890.28</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f45ac706-8b12-40ab-b4d1-87188d22a807">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">8194.63</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d4c14d98-9593-4bd3-a25f-916d159a3816">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">316989.42</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9bf7fb47-dc80-4f82-b527-46b280e27724">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">4523627.58</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a031412e-3975-419f-8f33-5f5ff8bd5ee8">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-18" />
      <value currency="USD" value-date="2025-12-18">-21726129.21</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="91d0373d-62c9-492e-b870-d910a21726ab">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-18" />
      <value currency="USD" value-date="2025-12-18">21693637.25</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="291168c7-efc0-4fa2-af81-6775db48053b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-18" />
      <value currency="USD" value-date="2025-12-18">-11061977.12</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0d751055-1be0-448d-8ff4-da6e8e0b8997">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-18" />
      <value currency="USD" value-date="2025-12-18">37637728.42</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b9c3c73c-49a0-4332-a8ea-8858121c3cc6">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">168860.98</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="825a32d9-25c6-470f-b4b8-50348f78d468">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">13013.01</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="55ba1596-fa3d-4788-b755-e4607ee114ee">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">302.63</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c51f1959-902f-48c9-bdd8-17cf7893682e">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-16" />
      <value currency="USD" value-date="2026-01-16">-21479281.54</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8e93726e-52f0-4d96-a2ab-fd748ced474b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-16" />
      <value currency="USD" value-date="2026-01-16">21602503.61</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b6d8415f-7b89-4911-b03d-4fffb4aac8c5">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-20" />
      <value currency="USD" value-date="2026-01-20">214355.71</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b0cfd282-266f-4a43-be08-a59e18589856">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-20" />
      <value currency="USD" value-date="2026-01-20">107382.84</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0f799fe5-995a-49d6-abf2-cb39f9065d65">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-20" />
      <value currency="USD" value-date="2026-01-20">68366.99</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ccfb5726-86c7-4b62-a378-9488cf59001d">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-22" />
      <value currency="USD" value-date="2026-01-22">-21534136.62</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="59f93e54-8d56-4610-b147-c94965a59bfa">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-22" />
      <value currency="USD" value-date="2026-01-22">21531431.02</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="df8f672e-4a2f-42ef-b32c-b326d4ca1e72">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-27" />
      <value currency="USD" value-date="2026-01-27">2015.97</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2809b43a-e976-4380-b405-cc78bb7831ed">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-02" />
      <value currency="USD" value-date="2026-02-02">21527798.61</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="18eb9900-b572-4d2e-901b-686963be9306">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-02" />
      <value currency="USD" value-date="2026-02-02">-21531431.02</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="07333231-7bb1-4436-b4ba-eb660e2a5127">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-03" />
      <value currency="USD" value-date="2026-02-03">-21527798.61</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1822dac6-68e2-40b2-aceb-742efd4ff8aa">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-03" />
      <value currency="USD" value-date="2026-02-03">24023715.92</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c8d28053-1be4-4f26-8bdd-7c96c5db61c6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-05" />
      <value currency="USD" value-date="2026-02-05">37191377.35</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="73afc85c-0aaf-403d-b973-894e4a60f333">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-05" />
      <value currency="USD" value-date="2026-02-05">-37346152.99</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b7d77b87-a10e-4579-8753-b7860aaad071">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-09" />
      <value currency="USD" value-date="2026-02-09">-2574.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b4590e8e-1f27-463b-95c2-1eb389a9298d">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-09" />
      <value currency="USD" value-date="2026-02-09">15089380.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="37aef147-85a1-4537-a179-e2a835cfd589">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-10" />
      <value currency="USD" value-date="2026-02-10">39529.12</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="893b7c17-9945-46c6-a901-05ad9453b664">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-17" />
      <value currency="USD" value-date="2026-02-17">15086806.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ceb9bd7a-1f0d-4b70-8ff4-a0cc750b111f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-17" />
      <value currency="USD" value-date="2026-02-17">358169.97</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="78044b93-a5c1-4e57-b9d4-4115c96888a8">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-17" />
      <value currency="USD" value-date="2026-02-17">1437935.50</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="150cf775-df94-4cdd-adbc-bb36a31ae57e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-03" />
      <value currency="USD" value-date="2026-03-03">6534.57</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="070f0777-7685-44bc-8a94-41c727b8e60a">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-10" />
      <value currency="USD" value-date="2026-03-10">269107.61</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c5608adb-27d1-4123-af98-afa94d279c91">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-10" />
      <value currency="USD" value-date="2026-03-10">2245.03</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a7892110-834f-4a48-aa5a-fb29ee1fb2eb">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-10" />
      <value currency="USD" value-date="2026-03-10">26940.30</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e5225985-2f6c-4db2-bc4a-e3af08a52dea">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-11" />
      <value currency="USD" value-date="2026-03-11">174035.12</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7c3fa397-a2f9-488c-8fc0-ac5ee2df96f6">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-11" />
      <value currency="USD" value-date="2026-03-11">117885.48</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="bcd8608c-e93b-4315-928a-5ab8a9503951">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-17" />
      <value currency="USD" value-date="2026-03-17">-35156693.74</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7d388d1c-db15-4032-983f-80ae2ad7f149">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-17" />
      <value currency="USD" value-date="2026-03-17">35624929.60</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ac9fd025-8a35-4949-9352-fb93ab338612">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-24" />
      <value currency="USD" value-date="2026-03-24">1633062.75</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0851893f-1d0f-4ecc-a8f5-775b49830762">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-24" />
      <value currency="USD" value-date="2026-03-24">360000.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0a51cad3-4c43-4e1a-a9f9-dbb498537047">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-24" />
      <value currency="USD" value-date="2026-03-24">2618169.35</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="63f37e93-a247-4c79-984d-510f35136a5e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-01" />
      <value currency="USD" value-date="2026-04-01">1932037.54</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fc22ce8c-e672-43b7-9c54-a73eb92a8440">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-01" />
      <value currency="USD" value-date="2026-04-01">34360384.46</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f81382df-f536-48f5-ace0-3790d9306866">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-01" />
      <value currency="USD" value-date="2026-04-01">17354267.40</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e8b04410-bd7e-49f9-b374-0a77e146e615">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-01" />
      <value currency="USD" value-date="2026-04-01">-17442747.19</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="50a71ae8-d520-4dcf-8058-219c297faa21">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-01" />
      <value currency="USD" value-date="2026-04-01">-35264929.60</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6ed01038-ff11-4612-a1ec-65fa875c80ba">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-08" />
      <value currency="USD" value-date="2026-04-08">1788257.74</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c910d6a2-f2f9-4f0d-b521-5c9cb6a8d9cb">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-20" />
      <value currency="USD" value-date="2026-04-20">15513813.06</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7a57619c-9641-440e-8d5c-7f150e28af44">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-20" />
      <value currency="USD" value-date="2026-04-20">30041549.62</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5a83f7c7-5426-4263-b551-048ded6c21ea">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-20" />
      <value currency="USD" value-date="2026-04-20">-15566009.66</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="28394de1-0227-4e7a-b0fb-9641441d9ca7">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-20" />
      <value currency="USD" value-date="2026-04-20">-30050231.15</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5aded1f4-7f9c-4584-9994-a6c1168df418">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-21" />
      <value currency="USD" value-date="2026-04-21">4296699.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="44117b81-59a7-4a0a-8bad-c542ccf27d20">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-21" />
      <value currency="USD" value-date="2026-04-21">13454.31</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b35faac9-013f-4740-97f1-7259a11a2b6d">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-21" />
      <value currency="USD" value-date="2026-04-21">-15513813.06</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5867236f-94d1-4cff-93d6-c9c7ccb39807">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-21" />
      <value currency="USD" value-date="2026-04-21">16651476.92</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c6de87fd-bee3-483e-af9c-b7a700484e8e">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-23" />
      <value currency="USD" value-date="2026-04-23">40520097.61</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="75aaf3c3-f163-49ca-b897-ea3091f74fbd">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-23" />
      <value currency="USD" value-date="2026-04-23">-30041549.62</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4f8607be-283f-4e0d-9fc9-9ebf1c198948">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">1000426.97</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="096f0db0-054d-447f-8a6b-75e29b6151e0">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">1493752.01</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="823205fa-a4b6-4b3c-8b51-5ac08bdf2781">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-30" />
      <value currency="USD" value-date="2026-04-30">-98.89</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="83be9833-bc57-4073-9765-c5c50ce3e630">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-30" />
      <value currency="USD" value-date="2026-04-30">40520196.50</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="149f15d3-a523-4a60-80fd-2e29fb433cfc">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-30" />
      <value currency="USD" value-date="2026-04-30">-40520097.61</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea2bb7ac-2b5d-425f-9195-88d28439bed4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-05" />
      <value currency="USD" value-date="2026-05-05">735620.53</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6278bc89-252a-48e4-aee1-bb5748caaaf7">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-05" />
      <value currency="USD" value-date="2026-05-05">108752.72</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fac00560-0819-4aca-bb50-f0a68a5a97b5">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-05" />
      <value currency="USD" value-date="2026-05-05">-13312924.69</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d5a8a0a9-3bdf-4ce0-af98-2a48cc247726">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-05" />
      <value currency="USD" value-date="2026-05-05">13308828.97</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7b8e7b55-8fe5-47e8-89af-527beb0ab0cb">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-09" />
      <value currency="USD" value-date="2026-05-09">-2574.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5e8021a3-d3f9-46ae-9b3d-63326b51181b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-09" />
      <value currency="USD" value-date="2026-05-09">29752451.01</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cd6a52f1-615c-4463-b15e-4f5e83087f2a">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-12" />
      <value currency="USD" value-date="2026-05-12">98146.13</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c058396b-9362-400b-9577-293c9d8ed6e5">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-05-12" />
      <value currency="USD" value-date="2026-05-12">98.89</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="95b9adc0-26ee-4926-9fa6-2fe2cbfb1214">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-19" />
      <value currency="USD" value-date="2026-05-19">8188796.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e0b586ff-335d-4157-bc18-a6b9bdd061b4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-19" />
      <value currency="USD" value-date="2026-05-19">7941.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="50e452b7-e8f5-4df6-8b28-74e3bab72a51">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-19" />
      <value currency="USD" value-date="2026-05-19">262571.73</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1e479cac-6c49-41e8-82be-e191c2b67cd4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-19" />
      <value currency="USD" value-date="2026-05-19">3536138.84</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c1442808-8eef-457e-96dc-26b4d58950b0">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-19" />
      <value currency="USD" value-date="2026-05-19">3092841.39</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="14c382bb-1c79-4739-b168-9ce6633e8cb8">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-26" />
      <value currency="USD" value-date="2026-05-26">14955.97</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c6024565-5d0d-4e8d-9718-a09b560a8b54">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-03" />
      <value currency="USD" value-date="2026-06-03">4145.85</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="afb78673-0137-480f-8a89-d2eda5c3d196">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-03" />
      <value currency="USD" value-date="2026-06-03">2565.58</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4668d4ac-c27a-4c4b-95e8-b3214df7fe31">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-03" />
      <value currency="USD" value-date="2026-06-03">3218.34</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a5a97854-1cde-4012-80f5-77b7d8862d06">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-05" />
      <value currency="USD" value-date="2026-06-05">-9674544.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="38e29971-c735-4ed2-9e51-4818d36bca32">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-05" />
      <value currency="USD" value-date="2026-06-05">10599296.30</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="87e866f3-6d06-4682-a247-f9e9295cb007">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-08" />
      <value currency="USD" value-date="2026-06-08">10539017.75</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7157db7c-a901-4c4c-b6eb-c4d07e27116a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-08" />
      <value currency="USD" value-date="2026-06-08">-10599296.30</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e71988f0-3661-4b1b-8b79-3509277dbcec">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-09" />
      <value currency="USD" value-date="2026-06-09">59044.22</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e7f4b86c-e389-4221-8763-11993a61fc2b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-09" />
      <value currency="USD" value-date="2026-06-09">36898.09</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d02b6f02-339d-4d1f-9cea-253c4f81a0c9">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-09" />
      <value currency="USD" value-date="2026-06-09">19471.02</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="540a23d1-a4f9-45ba-88da-7971bdb53686">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-09" />
      <value currency="USD" value-date="2026-06-09">83388.84</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4d6227f6-0809-4c10-ae92-0ecb147b669f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-09" />
      <value currency="USD" value-date="2026-06-09">92866.81</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="db796ed1-27d9-4470-95b3-6e8653721951">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-11" />
      <value currency="USD" value-date="2026-06-11">-10528689.59</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d745c3c1-66d1-46c9-8c80-2a775596c064">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-11" />
      <value currency="USD" value-date="2026-06-11">24357636.61</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="44637b74-f58f-426f-b419-2e2601021d3c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-16" />
      <value currency="USD" value-date="2026-06-16">3763118.78</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4466e3db-0f06-44a4-a927-9510ee921603">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-16" />
      <value currency="USD" value-date="2026-06-16">3756.46</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="269a951c-44b0-4ad1-ad5c-45ee383360a8">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-16" />
      <value currency="USD" value-date="2026-06-16">9908.16</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2d24831f-e20b-4806-aba2-d94376f9d58f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-16" />
      <value currency="USD" value-date="2026-06-16">558601.75</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1d35e9f5-8fc6-4c6a-89ac-6b2a0fa52ea3">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-16" />
      <value currency="USD" value-date="2026-06-16">420.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1b864eb0-d2f5-45ef-bdca-a6fb91a7c3b6">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-16" />
      <value currency="USD" value-date="2026-06-16">2306179.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2d7e22d8-4e84-436a-8d0e-f04e74fb4baf">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-23" />
      <value currency="USD" value-date="2026-06-23">2060185.14</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1f5d1fbe-6e12-4f21-b6e5-210b83475875">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-23" />
      <value currency="USD" value-date="2026-06-23">3336379.20</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1a98d9e8-446f-48a5-95d7-5fd2ca0a7948">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-23" />
      <value currency="USD" value-date="2026-06-23">203493.48</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b73254b6-d3e8-4046-9db0-c6a3fc5cffbe">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-26" />
      <value currency="USD" value-date="2026-06-26">-22093957.99</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a94a50e2-6e58-42ab-9bd2-a8c16a2cdd6f">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-26" />
      <value currency="USD" value-date="2026-06-26">22114510.49</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="143d2855-d674-42ad-89bc-baaa49bd519f">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-26" />
      <value currency="USD" value-date="2026-06-26">-20552.50</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fec38766-491e-4451-ae85-ce6c200e37dc">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-30" />
      <value currency="USD" value-date="2026-06-30">21894732.16</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a0c0b9ac-5378-4184-857a-8ec8c71e8f23">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-30" />
      <value currency="USD" value-date="2026-06-30">-21921460.67</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e6bdd93c-d3e8-41d9-9741-53fe2216f46a">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">234000.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d593c721-f3d7-46c1-ba4b-e24e0341c027">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">5568.88</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b5bccdec-8269-4db0-9602-980f45aa70bd">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">20552.50</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4870b551-cab1-4123-8449-9cf89b9a1cfa">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">14305.77</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3fd5fd70-40cc-4948-9a88-1af5c1db532f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">193049.82</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="00253a8e-9980-4fd3-9ce2-22beea4750d2">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-05" />
      <value currency="USD" value-date="2026-07-05">-31959296.84</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="091ecec7-6138-4190-b586-d9fb1212d298">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-05" />
      <value currency="USD" value-date="2026-07-05">29487210.79</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fd5e4026-ca3e-419f-9d96-0b2ba1b6dac4">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-06" />
      <value currency="USD" value-date="2026-07-06">21884647.70</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="83815614-4a08-4258-8bb8-54b32e83efe5">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-06" />
      <value currency="USD" value-date="2026-07-06">-21894732.16</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fe90684f-c66c-45a4-a545-079ffdfc6934">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">16105.87</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e399d364-7ec7-42f8-90c1-c8d212d74fd3">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">11000.31</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="98883147-9365-4334-963f-a5b76828a6ff">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">311.02</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="54795c23-d189-409a-92c6-f1246ed5fd02">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">30684.17</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ad269aa6-2b19-4dcb-b6f7-10e86c860f81">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-11" />
      <value currency="USD" value-date="2026-07-11">21901979.12</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="855c6021-35ff-49be-9274-d97aa71beb5b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-11" />
      <value currency="USD" value-date="2026-07-11">-21884647.70</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="65467031-9a46-4937-a548-30141da48026">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-11" />
      <value currency="USD" value-date="2026-07-11">-17331.42</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cf43cbcb-9332-4ab6-90ed-94621639c642">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">13360.08</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="cc0d9ad0-c882-4eb9-9820-48bbfd3962f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">2702848.85</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="054ce2cd-bc32-4723-b1e6-3320ed5934f5">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-15" />
      <value currency="USD" value-date="2026-07-15">21508048.47</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="39a7b46e-649b-44ed-9492-394caac356fb">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-15" />
      <value currency="USD" value-date="2026-07-15">-21901979.12</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="63f38976-d53b-4915-8990-b94032a9a5fe">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-16" />
      <value currency="USD" value-date="2026-07-16">-10.31</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6809ca8f-49a2-4ccc-84d5-89c719279cff">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-16" />
      <value currency="USD" value-date="2026-07-16">-26771001.86</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2e424651-87d0-4fc7-8325-97ce612c64e9">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-16" />
      <value currency="USD" value-date="2026-07-16">26771012.17</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="eca6d85d-17ba-4e69-97f9-6788546d8b4c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-17" />
      <value currency="USD" value-date="2026-07-17">-20950064.25</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="53ce7d22-3571-417c-a41b-f2a7104e65b6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-17" />
      <value currency="USD" value-date="2026-07-17">20948064.25</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a08a55e3-eaaa-4e00-be6a-e45f9af1baaa">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-21" />
      <value currency="USD" value-date="2026-07-21">9663733.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bce84714-d53b-41c7-aaf7-7971fc6d77bb">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-07-21" />
      <value currency="USD" value-date="2026-07-21">17331.42</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5085f471-672d-4ca0-94fd-db2c2a914003">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-21" />
      <value currency="USD" value-date="2026-07-21">557984.22</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7f956623-ddcb-458b-a239-51f9f62fac41">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-21" />
      <value currency="USD" value-date="2026-07-21">845254.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="378d7c88-f1d7-481d-bad7-0a60a72809fb">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-07-23" />
      <value currency="USD" value-date="2026-07-23">10.31</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fe7d35aa-d70f-44c8-811a-5d924ba2cc4e">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-25" />
      <value currency="USD" value-date="2026-07-25">23316866.67</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2986c3f3-aaff-4606-a99a-12a5654f98e8">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-25" />
      <value currency="USD" value-date="2026-07-25">-23713212.29</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c46e9a02-f18c-4bd9-96a7-9c9068e5b638">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-28" />
      <value currency="USD" value-date="2026-07-28">278298.71</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a3b0959f-bad7-4ef6-82c5-f1362129299b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-28" />
      <value currency="USD" value-date="2026-07-28">67813.12</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="80f3addb-2940-42e5-9afc-4eac4c9a0c83">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-28" />
      <value currency="USD" value-date="2026-07-28">3057808.22</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="836a4f18-3f1c-4b71-ade8-040db8c7222a">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-28" />
      <value currency="USD" value-date="2026-07-28">1218322.78</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="54b49eb2-e9b7-4877-8155-e005893b451e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-28" />
      <value currency="USD" value-date="2026-07-28">3057799.88</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="54d331e1-a9c7-4f6e-8880-9218bb6cb6eb">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">1662.19</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8855caa1-f6ce-444f-89fe-885204220df5">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-25" />
      <value currency="USD" value-date="2026-08-25">5460.50</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4cb5767f-9236-470c-8bf0-d23dac73b64f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-25" />
      <value currency="USD" value-date="2026-08-25">18752.05</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1d15e8d0-ef17-4477-9204-3c1baf8387f2">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-01" />
      <value currency="USD" value-date="2026-09-01">420.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="38425520-d683-4022-8e20-e91bd9f60696">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-15" />
      <value currency="USD" value-date="2026-09-15">371045.10</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7bf528b1-09fe-4f81-891a-d64459b0183b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-22" />
      <value currency="USD" value-date="2026-09-22">2784928.59</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="409cf97e-28a4-479c-a04b-19b1eed259f1">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-22" />
      <value currency="USD" value-date="2026-09-22">400353.83</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d0aa0861-0d7f-4281-a34c-ba1a469cdb76">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-23" />
      <value currency="USD" value-date="2026-09-23">-16838853.99</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2c988a55-573f-4dce-ade7-be60ae36c86e">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-23" />
      <value currency="USD" value-date="2026-09-23">17476464.88</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6f70a2f8-26cf-4d9a-8e1a-668c1b0ba95e">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-24" />
      <value currency="USD" value-date="2026-09-24">17328244.26</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3ed7a70b-b79b-4362-ba5f-9565f94a2435">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-24" />
      <value currency="USD" value-date="2026-09-24">-17761193.65</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d5a5e022-572d-4ba8-938e-e88413b2e291">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-26" />
      <value currency="USD" value-date="2026-09-26">-14593189.25</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3f147acc-ef6e-41ca-8042-29e9960022ca">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-26" />
      <value currency="USD" value-date="2026-09-26">14550019.89</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="00cec8ff-b5d4-4de8-82b2-1ef39e57e029">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">26187.83</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b2d4c11e-d502-45e2-85b9-5418ae5ad591">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">11644.06</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9e8ba981-884a-41a0-9db1-44b3689a669c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">2085237.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8041189b-97e9-4059-bff1-d39d4853636f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">1128915.77</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7c820e5a-c329-4344-b73a-2740d5a003c4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">2735055.01</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="197fe2b0-14b6-4bcf-8de8-ff68b9ec6081">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">114073.94</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="096d4dd1-c44b-4227-84f8-9c5ab5fc2d37">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">217028.48</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="508c4d44-1b20-4e2f-9376-59e448fc1581">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-01" />
      <value currency="USD" value-date="2026-10-01">-14550019.89</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2e12620c-391a-4c3a-8cc4-bc53a8d3fb74">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-01" />
      <value currency="USD" value-date="2026-10-01">17110289.62</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f237ce3e-a6d6-4de1-bb2f-93bc691ed7db">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-02" />
      <value currency="USD" value-date="2026-10-02">15587395.99</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5b38b765-bd51-43ba-b501-884234161a68">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-02" />
      <value currency="USD" value-date="2026-10-02">-234000.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="28e108ef-d23e-441e-ae2d-214c55319643">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-02" />
      <value currency="USD" value-date="2026-10-02">-15353395.99</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4e6f7979-102e-472b-896a-50c404f9dbe2">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-04" />
      <value currency="USD" value-date="2026-10-04">17083434.40</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2f2eb39f-7750-46f5-b3ed-8c869d4a6536">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-04" />
      <value currency="USD" value-date="2026-10-04">-17110289.62</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="df19e44c-3279-4039-83fc-cfc4770353f4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">147908.79</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b5070202-4706-4767-8821-336e58a4eedd">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">30546.23</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="867c0033-3b05-4ed5-a20e-2a02c6f953d3">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">360000.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7f7e7ed2-25ec-4361-9bd3-4dd09d090c65">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">234000.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6d7ae66f-228a-4927-8b79-2287e2b7f69f">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">234000.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="61fb8644-b852-4392-aa77-9d0a6d78c50c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">75971.18</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="562d4219-dc8d-4bf0-9864-269af0267b91">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">1696464.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b04808e8-6753-45a7-b998-74ee40f2446d">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">410389.21</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="26627053-1e1c-454c-a617-b37c74c713c6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">10578270.55</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0afb36ff-92aa-4ab2-8da6-3e344f582292">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">-5655647.62</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5aa8cda9-faaf-48da-a4dc-3d57dac75176">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-13" />
      <value currency="USD" value-date="2026-10-13">10553270.55</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b069146f-e997-4bb5-9141-9aa418f5252d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-13" />
      <value currency="USD" value-date="2026-10-13">33796.99</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="57e61d0a-8475-4cc8-9f11-153e7c712428">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-15" />
      <value currency="USD" value-date="2026-10-15">-410389.21</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="743717da-5d28-45ad-a766-64ad2036abc9">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-20" />
      <value currency="USD" value-date="2026-10-20">8964168.23</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1d2bae3f-0917-43aa-9733-9472a4952c1c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-20" />
      <value currency="USD" value-date="2026-10-20">863350.21</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fcf72511-8bea-45f1-a31f-5b478bc400f4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-27" />
      <value currency="USD" value-date="2026-10-27">124992.66</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="dfec22a8-140d-46c1-be05-fc48b14e0c3a">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-27" />
      <value currency="USD" value-date="2026-10-27">591219.91</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ba5c0c66-8751-469d-843c-40614c876b38">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-27" />
      <value currency="USD" value-date="2026-10-27">4719.31</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="292aed55-73ac-4004-8cd1-d2a62abc2849">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-27" />
      <value currency="USD" value-date="2026-10-27">112162.41</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c2023c49-2b99-4e45-a65b-60af6d5ede5f">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-30" />
      <value currency="USD" value-date="2026-10-30">-6630899.06</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2d54b8e5-37e3-49e2-80e1-f0f305677d66">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-30" />
      <value currency="USD" value-date="2026-10-30">6560998.52</value>
      <description>
        <narrative>Global Fund commitment to NGA-C-IHVNP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a46eae38-b9ad-4d99-8cbb-f52d0361d716">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">286800.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="18f7261f-4885-41e3-a449-6ec2374f53ce">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">111646.32</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1e80844e-3ab1-4b12-9169-eec1928b037f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">433200.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4eb0cb28-07f6-47d2-9ac8-0b02e2a18f4d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">14957.21</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6aa40f04-12a9-4e27-9715-e0115faae6fc">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">24853.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-C-IHVNP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="NGA-C-IHVNP01-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">31402685.45</value>
      <description>
        <narrative>Expenditure reported by Institute of Human Virology Nigeria for NGA-C-IHVNP01, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
    </transaction>
    <transaction ref="NGA-C-IHVNP01-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">92454355.78</value>
      <description>
        <narrative>Expenditure reported by Institute of Human Virology Nigeria for NGA-C-IHVNP01, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Institute of Human Virology Nigeria</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/NGA-C-IHVN" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-12" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/NGA/2023/TB_HIV/en/NGA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 1 - TB/HIV - Nigeria - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1535-NGA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-03-30" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="1">
        <narrative>3 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of US$ 73,453,224 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction of the Grantee’s compliance with the requirements listed at 5.3(1)(a) and 5.3(1)(b) below (“Co-Financing Requirements”). The Principal Recipient acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: a. progressively increase government expenditure on health to meet national universal health coverage goals; and/or b. increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Host Country shall, as set out in the co-financing commitment letter to be signed by the Government of Nigeria and submitted in form and substance satisfactory to the Global Fund, by 30 June 2024: (a) fulfil a total minimum co-financing commitment; (b) fulfil the programmatic commitments as stipulated in the co-financing commitment letter; and (c) provide to the Global Fund, by no later than the agreed date of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including but not limited to: i. the approved annual budget for HIV, TB and RSSH for the upcoming year; and ii. the total expenditure for HIV, TB and RSSH in the previous fiscal year.</narrative>
      </condition>
      <condition type="2">
        <narrative>4 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement.</narrative>
      </condition>
      <condition type="3">
        <narrative>5 - (1) Grant Funds may be used to pay for services performed by a fiscal agent retained by the Global Fund (the “Fiscal Agent”) and the Global Fund may disburse such Grant Funds directly to the Fiscal Agent; (2) The Principal Recipient consents to the terms of reference of the Fiscal Agent and agrees that such terms of reference may be amended from time to time at the Global Fund’s discretion; (3) The Principal Recipient shall cooperate fully with the Fiscal Agent to allow the Fiscal Agent to perform its services, including, but not limited to, by (a) providing all information requested by the Fiscal Agent or the Global Fund; (b) taking all necessary actions prior to collection of Personal Data and at all times thereafter to ensure that the processing of Personal Data by the Fiscal Agent does not violate any applicable law or regulation; and (c) implementing any recommendations made by the Fiscal Agent; and (4) The appointment of the Fiscal Agent shall not, nor shall it be construed to, discharge the Grantee nor the Principal Recipient of their respective obligations under the Grant Agreement, which shall remain in full force and effect. The Fiscal Agent shall not have authority to act as the Global Fund’s agent, unless provided otherwise in writing by the Global Fund. Accordingly, the Global Fund reserves the right to classify any expenditure of Grant Funds as non-compliant, notwithstanding its verification or endorsement by the Fiscal Agent.</narrative>
      </condition>
      <condition type="3">
        <narrative>6 - (1) Grant Funds may be used to pay for the services of an external auditor or for a Supreme Audit Institution approved by the Global Fund retained by the Global Fund for the annual independent audit of the Program (the “External Auditor”) and the Global Fund may disburse such Grant Funds directly to the External Auditor; and (2) without limiting Section 7.5 of the Global Fund Grant Regulations (as amended from time to time), the Principal Recipient shall cooperate fully with the External Auditor to allow the External Auditor to perform its services, including by providing all information and documents requested by the External Auditor or the Global Fund.</narrative>
      </condition>
      <condition type="1">
        <narrative>8 - US$2.6 million in matching funds will be made available to Nigeria (proportionally through the NGA-C-IHVN and NGA-H-NACA grants) for HIV prevention and HIV pre-exposure prophylaxis (PrEP). The performance based matching funds for these priority interventions, can only be accessed by the country if sufficient progress, as determined by the Global Fund, has been made toward achieving the Grant targets, as set out in the Performance Framework, for number of persons who received any PrEP product, by 30 June 2025.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
      </title>
      <description>
        <narrative>Module: Collaboration with other providers and sectors.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="91.89">
          <comment>
            <narrative>Numerator: 53496; Denominator: 58219.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="93">
            <comment>
              <narrative>Numerator: 32639; Denominator: 35096.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 65278; Denominator: 70192.</narrative>
            </comment>
          </target>
          <actual value="94.52">
            <comment>
              <narrative>Numerator: 102585; Denominator: 108530.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 32639; Denominator: 35096.</narrative>
            </comment>
          </target>
          <actual value="95.46">
            <comment>
              <narrative>Numerator: 61252; Denominator: 64164.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="93">
            <comment>
              <narrative>Numerator: 37995; Denominator: 40855.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 75990; Denominator: 81710.</narrative>
            </comment>
          </target>
          <actual value="94.45">
            <comment>
              <narrative>Numerator: 127436; Denominator: 134923.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 37995; Denominator: 40855.</narrative>
            </comment>
          </target>
          <actual value="94.42">
            <comment>
              <narrative>Numerator: 60550; Denominator: 64131.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="93">
            <comment>
              <narrative>Numerator: 47481; Denominator: 51055.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 47481; Denominator: 51055.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="92.73">
          <comment>
            <narrative>Numerator: 42705; Denominator: 46051.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="35">
            <comment>
              <narrative>Numerator: 16118; Denominator: 46051.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 42828; Denominator: 46051.</narrative>
            </comment>
          </target>
          <actual value="107.87">
            <comment>
              <narrative>Numerator: 49673; Denominator: 46051.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="58">
            <comment>
              <narrative>Numerator: 26710; Denominator: 46051.</narrative>
            </comment>
          </target>
          <actual value="76.42">
            <comment>
              <narrative>Numerator: 35192; Denominator: 46051.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 43748; Denominator: 46051.</narrative>
            </comment>
          </target>
          <actual value="111.09">
            <comment>
              <narrative>Numerator: 51156; Denominator: 46051.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 18420; Denominator: 46051.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="55">
            <comment>
              <narrative>Numerator: 25328; Denominator: 46051.</narrative>
            </comment>
          </target>
          <actual value="67.86">
            <comment>
              <narrative>Numerator: 31250; Denominator: 46051.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 23026; Denominator: 46051.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 23026; Denominator: 46051.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of at-risk AGYW that have received an HIV test during the reporting period in AGYW programs</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of at-risk AGYW that have received an HIV test during the reporting period in AGYW programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="15.64">
          <comment>
            <narrative>Numerator: 119559; Denominator: 764571.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="15">
            <comment>
              <narrative>Numerator: 114686; Denominator: 764571.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="40">
            <comment>
              <narrative>Numerator: 305829; Denominator: 764571.</narrative>
            </comment>
          </target>
          <actual value="13.78">
            <comment>
              <narrative>Numerator: 105396; Denominator: 764571.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="25">
            <comment>
              <narrative>Numerator: 191143; Denominator: 764571.</narrative>
            </comment>
          </target>
          <actual value="10.54">
            <comment>
              <narrative>Numerator: 80612; Denominator: 764571.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="21">
            <comment>
              <narrative>Numerator: 160560; Denominator: 764571.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="65">
            <comment>
              <narrative>Numerator: 496971; Denominator: 764571.</narrative>
            </comment>
          </target>
          <actual value="58.78">
            <comment>
              <narrative>Numerator: 449446; Denominator: 764571.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="44">
            <comment>
              <narrative>Numerator: 336411; Denominator: 764571.</narrative>
            </comment>
          </target>
          <actual value="43.9">
            <comment>
              <narrative>Numerator: 335614; Denominator: 764571.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="44">
            <comment>
              <narrative>Numerator: 336411; Denominator: 764571.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="51">
            <comment>
              <narrative>Numerator: 389931; Denominator: 764571.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <comment>
            <narrative>Numerator: 23702.8; Denominator: 23702.8.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 23703; Denominator: 23702.8.</narrative>
            </comment>
          </target>
          <actual value="117.1">
            <comment>
              <narrative>Numerator: 27757; Denominator: 23703.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 9481; Denominator: 23702.8.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 14222; Denominator: 23702.8.</narrative>
            </comment>
          </target>
          <actual value="75.1">
            <comment>
              <narrative>Numerator: 17802; Denominator: 23703.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 9481; Denominator: 23702.8.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 23703; Denominator: 23702.8.</narrative>
            </comment>
          </target>
          <actual value="123.05">
            <comment>
              <narrative>Numerator: 29166; Denominator: 23703.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 14222; Denominator: 23702.8.</narrative>
            </comment>
          </target>
          <actual value="73.72">
            <comment>
              <narrative>Numerator: 17473; Denominator: 23703.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 11852; Denominator: 23702.8.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 11852; Denominator: 23702.8.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <comment>
            <narrative>Numerator: 66756.67; Denominator: 66756.67.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 26703; Denominator: 66756.67.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 66757; Denominator: 66756.7.</narrative>
            </comment>
          </target>
          <actual value="97.79">
            <comment>
              <narrative>Numerator: 65280; Denominator: 66757.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 40054; Denominator: 66756.67.</narrative>
            </comment>
          </target>
          <actual value="75.73">
            <comment>
              <narrative>Numerator: 50556; Denominator: 66757.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 66757; Denominator: 66756.7.</narrative>
            </comment>
          </target>
          <actual value="93.31">
            <comment>
              <narrative>Numerator: 62294; Denominator: 66757.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 26703; Denominator: 66756.67.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 40054; Denominator: 66756.67.</narrative>
            </comment>
          </target>
          <actual value="67.33">
            <comment>
              <narrative>Numerator: 44948; Denominator: 66757.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 33379; Denominator: 66756.67.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 33379; Denominator: 66756.67.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 1817; Denominator: 7798; Percentage: 23.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 2061691; Denominator: 7707635; Percentage: 26.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 2061691; Denominator: 7707635; Percentage: 26.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 7276; Denominator: 7707635; Percentage: 0.09%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 7276; Denominator: 7707635; Percentage: 0.09%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 30%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1752; Denominator: 7798; Percentage: 22.47%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 30%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 937; Denominator: 7798; Percentage: 12.02%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 937.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 30%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1843; Denominator: 6906; Percentage: 26.69%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 955; Denominator: 6906; Percentage: 13.83%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 1858.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 45%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 50%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women who know their HIV status</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women who know their HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 548104; Denominator: 591962; Percentage: 92.59%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 55352.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 55352.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1892335.3; Denominator: 8697518; Percentage: 21.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 695830; Denominator: 8697518; Percentage: 8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 909889; Denominator: 8697518; Percentage: 10.46%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 982446.28; Denominator: 8697518; Percentage: 11.3%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 473893; Denominator: 8697518; Percentage: 5.45%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 473893.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1371627.98; Denominator: 8896113; Percentage: 15.42%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2820608; Denominator: 8896113; Percentage: 31.7%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1416284; Denominator: 8896113; Percentage: 15.92%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1448979.98; Denominator: 8896113; Percentage: 16.29%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 701651; Denominator: 8896113; Percentage: 7.89%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 4767.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1710093.49; Denominator: 9100724; Percentage: 18.79%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1789224.49; Denominator: 9100724; Percentage: 19.66%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of at-risk adolescent girls and young women reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of at-risk adolescent girls and young women reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 154980; Denominator: 764571; Percentage: 20.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 7796; Denominator: 282043; Percentage: 2.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 7796; Denominator: 282043; Percentage: 2.76%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 458742; Denominator: 764571; Percentage: 60%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 137573; Denominator: 764571; Percentage: 17.99%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 152914; Denominator: 764571; Percentage: 20%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 305828; Denominator: 764571; Percentage: 40%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 109016; Denominator: 764571; Percentage: 14.26%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 70277.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 305828; Denominator: 764571; Percentage: 40%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 764571; Denominator: 764571; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 923272; Denominator: 764571; Percentage: 120.76%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 458743; Denominator: 764571; Percentage: 60%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 643691; Denominator: 764571; Percentage: 84.19%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 366626; Denominator: 923272; Percentage: 39.71%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 382285.5; Denominator: 764571; Percentage: 50%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 382285.5; Denominator: 764571; Percentage: 50%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of MSM who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of MSM who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 8439; Denominator: 34538; Percentage: 24.43%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 12436.9.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13365.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 12436.95.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13365.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 18114.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 23075.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 18114.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 23075.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 18496.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="92.73">
          <comment>
            <narrative>Numerator: 42705; Denominator: 46051.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 18420; Denominator: 46051.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 45130; Denominator: 46051.</narrative>
            </comment>
          </target>
          <actual value="107.73">
            <comment>
              <narrative>Numerator: 49611; Denominator: 46051.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="58">
            <comment>
              <narrative>Numerator: 26710; Denominator: 46051.</narrative>
            </comment>
          </target>
          <actual value="76.29">
            <comment>
              <narrative>Numerator: 35131; Denominator: 46051.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 45130; Denominator: 46051.</narrative>
            </comment>
          </target>
          <actual value="139.2">
            <comment>
              <narrative>Numerator: 64105; Denominator: 46051.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="43">
            <comment>
              <narrative>Numerator: 19802; Denominator: 46051.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="55">
            <comment>
              <narrative>Numerator: 25328; Denominator: 46051.</narrative>
            </comment>
          </target>
          <actual value="80.34">
            <comment>
              <narrative>Numerator: 36996; Denominator: 46051.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 23026; Denominator: 46051.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 23026; Denominator: 46051.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of PWID who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for people who use drugs (PUD) and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of PWID who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2919; Denominator: 21095; Percentage: 13.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 150; Denominator: 3932; Percentage: 3.81%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 150; Denominator: 3932; Percentage: 3.81%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 1222131; Denominator: 1244707; Percentage: 98.19%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 1222131; Denominator: 1244707; Percentage: 98.19%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 689371; Denominator: 739463; Percentage: 93.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 689371; Denominator: 739463; Percentage: 93.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="PrEP product" value="DPV-VR" />
          <comment>
            <narrative>Numerator: 2547; Denominator: 3932; Percentage: 64.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="PrEP product" value="DPV-VR" />
          <comment>
            <narrative>Numerator: 2547; Denominator: 3932; Percentage: 64.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="PrEP product" value="Injectable PrEP" />
          <comment>
            <narrative>Numerator: 1385; Denominator: 3932; Percentage: 35.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="PrEP product" value="Injectable PrEP" />
          <comment>
            <narrative>Numerator: 1385; Denominator: 3932; Percentage: 35.22%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4301.9.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8815.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4301.87.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8815.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 734.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 2866.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 5215.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="PrEP product" value="DPV-VR" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="PrEP product" value="Injectable PrEP" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4729.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13006.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4728.98.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13006.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 908.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 2877.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 9221.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="PrEP product" value="DPV-VR" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="PrEP product" value="Injectable PrEP" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5175.77.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of needles and syringes distributed per person who injects drugs per year by needle and syringe programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for people who use drugs (PUD) and their sexual partners.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of needles and syringes distributed per person who injects drugs per year by needle and syringe programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="82088" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="447080" />
          <actual value="180956" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="447080" />
          <actual value="180956" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="558850" />
          <actual value="1006657" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="558850" />
          <actual value="1006657" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="670620" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for people who use drugs (PUD) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <comment>
            <narrative>Numerator: 23702.8; Denominator: 23702.8.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 9481; Denominator: 23703.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 23703; Denominator: 23703.</narrative>
            </comment>
          </target>
          <actual value="118.46">
            <comment>
              <narrative>Numerator: 28078; Denominator: 23703.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 14222; Denominator: 23703.</narrative>
            </comment>
          </target>
          <actual value="76.42">
            <comment>
              <narrative>Numerator: 18115; Denominator: 23703.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 9481; Denominator: 23703.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 23703; Denominator: 23703.</narrative>
            </comment>
          </target>
          <actual value="169.9">
            <comment>
              <narrative>Numerator: 40271; Denominator: 23703.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 14222; Denominator: 23703.</narrative>
            </comment>
          </target>
          <actual value="97.95">
            <comment>
              <narrative>Numerator: 23218; Denominator: 23703.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 11852; Denominator: 23703.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 11852; Denominator: 23703.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 20572; Denominator: 56410; Percentage: 36.47%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 30317.9.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30331.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 30317.91.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30331.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 44157.7.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 36751.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 44157.7.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 36751.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 45089.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <comment>
            <narrative>Numerator: 66756.67; Denominator: 66756.67.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 66757; Denominator: 66757.</narrative>
            </comment>
          </target>
          <actual value="97.86">
            <comment>
              <narrative>Numerator: 65329; Denominator: 66757.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 26703; Denominator: 66757.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 40054; Denominator: 66757.</narrative>
            </comment>
          </target>
          <actual value="75.8">
            <comment>
              <narrative>Numerator: 50605; Denominator: 66757.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 26703; Denominator: 66757.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 66757; Denominator: 66757.</narrative>
            </comment>
          </target>
          <actual value="141.51">
            <comment>
              <narrative>Numerator: 94467; Denominator: 66757.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 40054; Denominator: 66757.</narrative>
            </comment>
          </target>
          <actual value="84.49">
            <comment>
              <narrative>Numerator: 56403; Denominator: 66757.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 33379; Denominator: 66757.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 33379; Denominator: 66757.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of health service delivery sites with a community-led monitoring mechanism in place</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Community systems strengthening.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of health service delivery sites with a community-led monitoring mechanism in place</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="33.33">
          <comment>
            <narrative>Numerator: 240; Denominator: 720.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="33.3">
            <comment>
              <narrative>Numerator: 240; Denominator: 720.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 720.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="33.33">
            <comment>
              <narrative>Numerator: 240; Denominator: 720.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 720.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="66.7">
            <comment>
              <narrative>Numerator: 480; Denominator: 720.</narrative>
            </comment>
          </target>
          <actual value="46.67">
            <comment>
              <narrative>Numerator: 336; Denominator: 720.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="66.67">
            <comment>
              <narrative>Numerator: 480; Denominator: 720.</narrative>
            </comment>
          </target>
          <actual value="46.67">
            <comment>
              <narrative>Numerator: 336; Denominator: 720.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 720; Denominator: 720.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="43.05">
          <comment>
            <narrative>Numerator: 122933; Denominator: 285561.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="32.7">
            <comment>
              <narrative>Numerator: 112730; Denominator: 344574.</narrative>
            </comment>
          </target>
          <actual value="36.72">
            <comment>
              <narrative>Numerator: 148849; Denominator: 405324.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="32.7">
            <comment>
              <narrative>Numerator: 56365; Denominator: 172287.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="32.7">
            <comment>
              <narrative>Numerator: 56365; Denominator: 172287.</narrative>
            </comment>
          </target>
          <actual value="22.04">
            <comment>
              <narrative>Numerator: 76915; Denominator: 348959.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="32.7">
            <comment>
              <narrative>Numerator: 122728; Denominator: 375140.</narrative>
            </comment>
          </target>
          <actual value="40.25">
            <comment>
              <narrative>Numerator: 184567; Denominator: 458534.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="32.71">
            <comment>
              <narrative>Numerator: 61364; Denominator: 187570.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="32.71">
            <comment>
              <narrative>Numerator: 61364; Denominator: 187570.</narrative>
            </comment>
          </target>
          <actual value="36.96">
            <comment>
              <narrative>Numerator: 100147; Denominator: 270964.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="32.71">
            <comment>
              <narrative>Numerator: 65730; Denominator: 200913.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="32.71">
            <comment>
              <narrative>Numerator: 65730; Denominator: 200913.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 69504; Denominator: 285561; Percentage: 24.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 55352.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 55352.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 35096; Denominator: 172287; Percentage: 20.3%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 70192; Denominator: 344574; Percentage: 20.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 134923; Denominator: 405324; Percentage: 33.29%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 35096; Denominator: 172287; Percentage: 20.3%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 64131; Denominator: 370228; Percentage: 17.32%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 109785.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 81710; Denominator: 375140; Percentage: 21.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 154967; Denominator: 458534; Percentage: 33.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 40855; Denominator: 187570; Percentage: 21.8%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40855; Denominator: 187570; Percentage: 21.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 82092; Denominator: 270964; Percentage: 30.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 92671.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 51055; Denominator: 200915; Percentage: 25.4%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 51055; Denominator: 200915; Percentage: 25.4%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="94.17">
          <comment>
            <narrative>Numerator: 346369; Denominator: 367799.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 106692; Denominator: 112307.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 213384; Denominator: 224614.</narrative>
            </comment>
          </target>
          <actual value="98.48">
            <comment>
              <narrative>Numerator: 196993; Denominator: 200042.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 106692; Denominator: 112307.</narrative>
            </comment>
          </target>
          <actual value="98.74">
            <comment>
              <narrative>Numerator: 121557; Denominator: 123108.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 124197; Denominator: 130734.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 248395; Denominator: 261468.</narrative>
            </comment>
          </target>
          <actual value="88.04">
            <comment>
              <narrative>Numerator: 399199; Denominator: 453432.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 124198; Denominator: 130734.</narrative>
            </comment>
          </target>
          <actual value="82.61">
            <comment>
              <narrative>Numerator: 242463; Denominator: 293487.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 155207; Denominator: 163376.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 155207; Denominator: 163376.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 77346.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 77346.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="TPT regimen" value="3RH" />
          <comment>
            <narrative>Numerator: 29736.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="TPT regimen" value="3RH" />
          <comment>
            <narrative>Numerator: 29736.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="TPT regimen" value="6H" />
          <comment>
            <narrative>Numerator: 81053.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="TPT regimen" value="6H" />
          <comment>
            <narrative>Numerator: 81053.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Percentage: 90.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Percentage: 90.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Percentage: 80.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Percentage: 80.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="TPT regimen" value="RIF" />
          <comment>
            <narrative>Percentage: 89.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="TPT regimen" value="RIF" />
          <comment>
            <narrative>Percentage: 89.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Percentage: 87.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Percentage: 87.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 9647.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="3HP" />
          <comment>
            <narrative>Numerator: 966.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="3HP" />
          <comment>
            <narrative>Numerator: 966.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 35363.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 35363.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 43010.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 86020.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 119286.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 43010.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 79644.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3HP" />
            <comment>
              <narrative>Numerator: 12847.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3RH" />
            <comment>
              <narrative>Numerator: 11070.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="6H" />
            <comment>
              <narrative>Numerator: 83062.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 23822.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 119286.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="RIF" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 119286.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 100134.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 149936.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 50067.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 50067.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 90693.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 119677.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3HP" />
            <comment>
              <narrative>Numerator: 101438.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3RH" />
            <comment>
              <narrative>Numerator: 17175.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="6H" />
            <comment>
              <narrative>Numerator: 27997.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 13788.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="RIF" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 62568.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 62568.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="96.13">
          <comment>
            <narrative>Numerator: 894; Denominator: 930.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="98.72">
            <comment>
              <narrative>Numerator: 774; Denominator: 784.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 417; Denominator: 417.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="99.02">
            <comment>
              <narrative>Numerator: 704; Denominator: 711.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="98.76">
            <comment>
              <narrative>Numerator: 397; Denominator: 402.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 13899; Denominator: 98666; Percentage: 14.09%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1708370; Denominator: 1860826; Percentage: 91.81%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1708370; Denominator: 1860826; Percentage: 91.81%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="3RH" />
          <comment>
            <narrative>Numerator: 44218; Denominator: 44218; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="3RH" />
          <comment>
            <narrative>Numerator: 44218; Denominator: 44218; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="6H" />
          <comment>
            <narrative>Numerator: 638278; Denominator: 689371; Percentage: 92.59%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="6H" />
          <comment>
            <narrative>Numerator: 638278; Denominator: 689371; Percentage: 92.59%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1131747; Denominator: 1222131; Percentage: 92.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1131747; Denominator: 1222131; Percentage: 92.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="RIF" />
          <comment>
            <narrative>Numerator: 6458; Denominator: 6458; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="RIF" />
          <comment>
            <narrative>Numerator: 6458; Denominator: 6458; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 86331; Denominator: 103612; Percentage: 83.32%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 15%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 83904; Denominator: 103612; Percentage: 80.98%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 84063.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3RH" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="6H" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 28176.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="RIF" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 17%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 17%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 104119; Denominator: 113891; Percentage: 91.42%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 17%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 15168; Denominator: 113891; Percentage: 13.32%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 102689.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3RH" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="6H" />
            <comment>
              <narrative>Numerator: 104119.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 35592.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="RIF" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="99.97">
          <comment>
            <narrative>Numerator: 11461; Denominator: 11465.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 7684; Denominator: 7684.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="100.23">
            <comment>
              <narrative>Numerator: 4297; Denominator: 4287.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 9026; Denominator: 9026.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 4379; Denominator: 4379.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 4096; Denominator: 10987; Percentage: 37.28%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4395; Denominator: 10987.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6592; Denominator: 10987; Percentage: 60%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2876; Denominator: 10987; Percentage: 26.18%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6592; Denominator: 10987; Percentage: 60%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2876; Denominator: 10987; Percentage: 26.18%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 7076; Denominator: 10108; Percentage: 70%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7581; Denominator: 10108; Percentage: 75%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2763; Denominator: 10108; Percentage: 27.33%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7581; Denominator: 10108; Percentage: 75%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2763; Denominator: 10108; Percentage: 27.33%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8006; Denominator: 8895; Percentage: 90.01%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8895; Denominator: 8895; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="45.27">
          <comment>
            <narrative>Numerator: 44670; Denominator: 98666.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 98726; Denominator: 103923.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 101258; Denominator: 106587.</narrative>
            </comment>
          </target>
          <actual value="85.52">
            <comment>
              <narrative>Numerator: 86598; Denominator: 101258.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 101258; Denominator: 106587.</narrative>
            </comment>
          </target>
          <actual value="85.52">
            <comment>
              <narrative>Numerator: 86598; Denominator: 101258.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 107586; Denominator: 113248.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 113915; Denominator: 119910.</narrative>
            </comment>
          </target>
          <actual value="85.06">
            <comment>
              <narrative>Numerator: 102001; Denominator: 119910.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 113915; Denominator: 119910.</narrative>
            </comment>
          </target>
          <actual value="85.06">
            <comment>
              <narrative>Numerator: 102001; Denominator: 119910.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 115695.75; Denominator: 121785.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 122333.4; Denominator: 128772.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 98666; Denominator: 133234; Percentage: 74.05%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 11052; Denominator: 26145; Percentage: 42.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 11052; Denominator: 26145; Percentage: 42.27%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 106587; Denominator: 130352; Percentage: 81.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 103612; Denominator: 130352; Percentage: 79.49%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 103923; Denominator: 130352; Percentage: 80%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 106587; Denominator: 130352; Percentage: 81.77%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 103612; Denominator: 130352; Percentage: 79.49%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 68117.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 119910; Denominator: 128772; Percentage: 93.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 113891; Denominator: 128772; Percentage: 88.44%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 113248; Denominator: 128772; Percentage: 87.94%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 119910; Denominator: 128772; Percentage: 93.12%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 113891; Denominator: 128772; Percentage: 88.44%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 76450; Denominator: 113891; Percentage: 67.13%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 121785; Denominator: 128772; Percentage: 94.57%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 128772; Denominator: 128772; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="27.49">
          <comment>
            <narrative>Numerator: 2144; Denominator: 7798.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 7798; Denominator: 7798.</narrative>
            </comment>
          </target>
          <actual value="34.51">
            <comment>
              <narrative>Numerator: 2691; Denominator: 7798.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 3899; Denominator: 7798.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 3899; Denominator: 7798.</narrative>
            </comment>
          </target>
          <actual value="16.23">
            <comment>
              <narrative>Numerator: 1266; Denominator: 7798.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 6906; Denominator: 6906.</narrative>
            </comment>
          </target>
          <actual value="59.35">
            <comment>
              <narrative>Numerator: 4099; Denominator: 6906.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 3453; Denominator: 6906.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 3453; Denominator: 6906.</narrative>
            </comment>
          </target>
          <actual value="27.53">
            <comment>
              <narrative>Numerator: 1901; Denominator: 6906.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="50.01">
            <comment>
              <narrative>Numerator: 3237; Denominator: 6473.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="50.01">
            <comment>
              <narrative>Numerator: 3237; Denominator: 6473.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>